- Home
- MRNA vs CX Comparison
MRNA vs CX Comparison
Compare MRNA & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | CX |
|---|---|---|
| Founded | 2010 | 1906 |
| Country | United States | Mexico |
| Employees | N/A | 39462 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 17.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | CX |
|---|---|---|
| Price | $45.54 | $12.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $34.27 | $12.21 |
| AVG Volume (30 Days) | 5.1M | ★ 5.6M |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | $8.28 |
| Revenue Next Year | $15.43 | $4.34 |
| P/E Ratio | ★ N/A | $19.03 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $5.94 |
| 52 Week High | $59.55 | $13.35 |
Technical Indicators
Market Signals| Indicator | MRNA | CX |
|---|---|---|
| Relative Strength Index (RSI) | 34.72 | 57.75 |
| Support Level | $23.52 | $11.53 |
| Resistance Level | $55.36 | $13.25 |
| Average True Range (ATR) | 2.76 | 0.35 |
| MACD | -0.87 | 0.04 |
| Stochastic Oscillator | 7.99 | 55.74 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.